LV- and RV-derived MM hydrogels improve RV contractility over time, preserve RV volumes, and reduce RV-free wall thickness.
LV-derived MM hydrogels improve RVEF.
LV- and RV-derived MM hydrogels reduce hypertrophy and interstitial fibrosis, decrease myofibroblast density, and enhance neovascularization.
Although both MM hydrogels enhance gene expression related to neovascularization, contractility, and cardiac development, the RV-derived MM hydrogel enhances inflammatory and fibrotic gene expression, suggesting greater therapeutic benefit of the LV-derived MM hydrogel.
This study evaluates the effectiveness of myocardial matrix (MM) hydrogels in mitigating negative right ventricular (RV) remodeling in a rat model of RV heart failure. The goal was to assess whether a hydrogel derived from either the right or left ventricle could promote cardiac repair. Injured rat right ventricles were injected with either RV-or left ventricular–derived MM hydrogels. Both hydrogels improved RV function and morphology and reduced negative remodeling. This study supports the potential of injectable biomaterial therapies for treating RV heart failure.